Sign in

Joseph Sassine

@josephsassinemd.bsky.social
387 followers 227 following 34 posts

Transplant ID Faculty & ID Fellowship APD at University of Oklahoma | #TxID | Cancer ID | #ChemalyTeam | Views my own | RT ≠ endorsement | 🇫🇷🇱🇧

PostsRepliesMedia
Joseph Sassine @josephsassinemd.bsky.social · 26/03/2026
Happy to share news of my upcoming promotion to Associate Professor of Medicine at @ou.edu starting this July. Grateful to my mentors and colleagues who helped make it happen, including those who wrote letters of support for my promotion.
280
Reposted by Joseph Sassine
Clinical Infectious Diseases @cidjournal.bsky.social · 12/01/2026
Evaluation of a Remote Therapeutic Monitoring (RTM) Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy (OPAT) ✅ Just Accepted 🔗 bit.ly/4spq9ts
bit.ly
Evaluation of a Remote Therapeutic Monitoring (RTM) Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy (OPAT)
AbstractBackground. Unplanned healthcare utilization events, including hospital readmissions and emergency room (ER) visits, are common in patients receivi
012
Joseph Sassine @josephsassinemd.bsky.social · 08/01/2026
Out now in @cidjournal.bsky.social my first ever investigator-initiated funded study - A pilot trial evaluating IV Ensure, a remote therapeutic monitoring device in OPAT! #IDSky #OPAT Open access thanks to @ou.edu libraries so check it out! Key highlights in 🧵 academic.oup.com/cid/advance-...
academic.oup.com
Evaluation of a Remote Therapeutic Monitoring (RTM) Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy (OPAT)
AbstractBackground. Unplanned healthcare utilization events, including hospital readmissions and emergency room (ER) visits, are common in patients receivi
271
Joseph Sassine @josephsassinemd.bsky.social · 03/12/2025
Come train with us! We have two open spots for ID fellowship at @ou.edu Great clinical exposure, academic tracks (TxID, healthcare admin/hospital epi, trop med/global health, CCM fellowship), 12-credit certificates covered by the program. #IDSky #TxID #MedEd medicine.ouhsc.edu/academic-dep...
medicine.ouhsc.edu
Curriculum
185
Joseph Sassine @josephsassinemd.bsky.social · 18/10/2025
Also out now in American Journal of Medical Sciences, our review of infectious complications of CAR T and BsAb, led by @ou.edu ID fellow Bradley Dye, a good primer for trainees and faculty alike! #TxID #IDSky www.amjmedsci.org/article/S000...
amjmedsci.org
Infectious Complications of Chimeric Antigen Receptor T Cell Therapy and Bispecific Antibodies – A Review
Chimeric antigen receptor (CAR) T cell therapy has shifted the therapeutic landscape of hematological malignancies in the last decade, and bispecific antibodies (BsAb) are an emerging treatment for th...
040
Joseph Sassine @josephsassinemd.bsky.social · 10/10/2025
Out now in @ichejournal.bsky.social , with @ritawilson.bsky.social and others, our report on the blood culture bottle shortage last year affecting the diagnostic yield in febrile neutropenia @ou.edu #TxID #IDSky doi.org/10.1017/ice....
doi.org
Diagnostic yield of blood cultures in febrile neutropenia—a real-world observational study from an academic medical center during blood culture bottle shortage | Infection Control & Hospital Epide...
Diagnostic yield of blood cultures in febrile neutropenia—a real-world observational study from an academic medical center during blood culture bottle shortage
141
Reposted by Joseph Sassine
ASHE Journal @ashejournal.bsky.social · 31/07/2025
@bryanpwhite.bsky.social et al: In a cohort (n=127) of OPAT patients on daptomycin 7.4 mg/kg for an average of 37 days, the rate of CK elevation was 11.8% at a median of 13 days (IQR 9-16) supporting weekly lab monitoring on daptomycin for OPAT. doi.org/10.1017/ash....
doi.org
Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy - Volume 5 Issue 1
154
Reposted by Joseph Sassine
JAC-AMR @jac-amr.bsky.social · 15/07/2025
This study offers real-world data evaluating the ePlex BCID-FP rapid identification system for yeast and found it was less sensitive than previously reported and infrequently led to de-escalation of antifungals doi.org/10.1093/jaca... @josephsassinemd.bsky.social #JACAMRNews #IDSKy
011
Joseph Sassine @josephsassinemd.bsky.social · 14/07/2025
ID fellowship applicants, make sure to check out our program @ou.edu: 2 year clinical program - 3 tracks (TxID, hosp epi, trop med) - Path for crit care fellowship - 12 credit certificates in year 2 #TxID #IDSky #MedEd medicine.ouhsc.edu/academic-dep...
medicine.ouhsc.edu
Curriculum
010
Joseph Sassine @josephsassinemd.bsky.social · 27/06/2025
Out now in @jac-amr.bsky.social, our real world analysis of BCID fungal panel for diagnosis of fungemia, led by the great Emily Siegrist - Sensitivity of 94%, lower than anticipated @bryanpwhite.bsky.social @ritawilson.bsky.social #IDSky academic.oup.com/jacamr/artic...
academic.oup.com
Evaluation of a rapid identification panel for fungemia
Abstract. Bloodstream infections due to yeast are associated with a high mortality rate. There is a lack of data that evaluate the real-world sensitivity o
153
Joseph Sassine @josephsassinemd.bsky.social · 15/05/2025
And part 2 is out now: How to prevent travel-related infections in the transplant recipient, check it out! @ritawilson.bsky.social @andhen25.bsky.social #IDSky #TxID journals.sagepub.com/doi/full/10....
journals.sagepub.com
Prevention of travel-related infections in solid organ and hematopoietic cell transplant recipients - Rita Wilson Dib, José Henao-Cordero, Joseph Sassine, Emily A. Siegrist, Nelson Iván Agudelo Higuit...
The growing population of transplant survivors receiving a solid organ transplantation (SOT) or a hematopoietic cell transplantation (HCT) and the emergence of ...
031
Joseph Sassine @josephsassinemd.bsky.social · 08/05/2025
Invasive fusariosis after CAR T is rare but can be consequential. Here’s our case of cutaneous fusariosis after CD19 CAR T, with @ritawilson.bsky.social @ouholter.bsky.social and others, out in @asm.org Case Reports! #TxID journals.asm.org/doi/10.1128/...
journals.asm.org
Invasive fusariosis after CD19 chimeric antigen receptor T-cell therapy | ASM Case Reports
Invasive fusariosis is a rare entity that primarily affects patients with hematological malignancies and recipients of hematopoietic cell transplants. Cases of mold infections in chimeric antigen receptor T-cell (CAR-T) therapy recipients have seldom been reported (1–6). We herein present this case of invasive fusariosis managed with combination antifungal therapy. Additionally, we provide a succinct review of cases reported in existing literature.
031
Joseph Sassine @josephsassinemd.bsky.social · 10/04/2025
Had a great time in Syracuse presenting Medicine Grand Rounds earlier today on Infections after CAR T at SUNY Upstate and meeting some great ID colleagues there! #TxID
020
Joseph Sassine @josephsassinemd.bsky.social · 11/02/2025
Excited to launch new tracks in our 2-year ID fellowship program @ou.edu starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care. Tracks come with option for 12-credit certificates, covered by the program: medicine.ouhsc.edu/academic-dep... 🧵 #IDSky #TxID
medicine.ouhsc.edu
Curriculum
131
Joseph Sassine @josephsassinemd.bsky.social · 23/01/2025
How to prevent infections in the increasingly immunocompromised traveler? Part 1 (non-transplant) is out now! Stay tuned for part 2! @ritawilson.bsky.social @andhen25.bsky.social @ou.edu #IDSky #TxID journals.sagepub.com/doi/10.1177/...
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
0126
Joseph Sassine @josephsassinemd.bsky.social · 18/01/2025
Out now, everything you need to know, that is known and not known, about herpesviruses after CAR T and BsAb, in our review with Dr Emily Siegrist and Dr Roy Chemaly! @mdanderson.bsky.social @ou.edu #IDSky #TxID www.mdpi.com/1999-4915/17...
mdpi.com
Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review
In this narrative review, we explore the burden and risk factors of various herpesvirus infections in patients receiving chimeric antigen receptor T-cell (CAR-T) therapy or bispecific antibodies (BsAb...
080
Joseph Sassine @josephsassinemd.bsky.social · 14/01/2025
Spoke to @koconews.bsky.social about norovirus, clinical presentation and preventive measures #IDSky www.koco.com/article/okla...
koco.com
How Oklahomans can protect themselves from norovirus, or 'stomach bug'
A stomach bug sweeping the country has infected hundreds of patients in its path.
020
Reposted by Joseph Sassine
Paul Abramson MD @paulabramsonmd.mydoctorsf.com · 29/12/2024
T-SPOT.TB performs much better in many immunocompromised populations IMO, but historically was logistically more difficult from CA due to time-sensitive FedEx of samples to Memphis which failed a lot with winter storms. Less an issue now that Quest bought T-SPOT.
081
Reposted by Joseph Sassine
Kyle Walding @tbrnaughttb.bsky.social · 29/12/2024
T-SPOT resulted in - fewer indeterminate results (than QFT) - more “actionable” results (than QFT) in certain immunocompromised populations #TBSky
0123
Joseph Sassine @josephsassinemd.bsky.social · 28/12/2024
Out now in @thetxidjournal.bsky.social! T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB. #TxID #IDSky onlinelibrary.wiley.com/doi/10.1111/...
1267
Reposted by Joseph Sassine
JAC-AMR @jac-amr.bsky.social · 27/12/2024
A retrospective cohort study of Gram-negative BSIs in ICU shows fever, lack of source control and time to repeat follow-up blood culture (FUBC) as risk factors for repeat positive FUBC: doi.org/10.1093/jacamr/dlae144 #JACAMRNews @bryanpwhite.bsky.social
doi.org
Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemia
AbstractObjectives. To evaluate the utility of follow-up blood cultures (FUBCs) for Gram-negative bloodstream infection (BSI) in ICU patients and identify
032
Joseph Sassine @josephsassinemd.bsky.social · 18/12/2024
Special theme issue in @cmijournal.bsky.social - Infections in immunocompromised hosts, edited by Dr Roy Chemaly, with a series of high yield #TxID reviews, including our review of herpesviruses after allogeneic HCT #IDSky www.clinicalmicrobiologyandinfection.com/article/S119...
clinicalmicrobiologyandinfection.com
DEFINE_ME
271
Joseph Sassine @josephsassinemd.bsky.social · 15/12/2024
Recently spoke with Health IT News about the results of our innovative trial of remote therapeutic monitoring in OPAT, how RTM helped us reduce infection-related readmissions and improve patient adherence to IV ABx #IDSky #OPAT @ou.edu www.healthcareitnews.com/news/remote-...
healthcareitnews.com
Remote therapeutic monitoring reduces readmissions, academic research shows
The University of Oklahoma College of Medicine did a controlled test and showed the odds of infection-related readmissions were decreased in the RTM group by 76% at 30 days, 80% at 60 days and 68% at ...
1142
Joseph Sassine @josephsassinemd.bsky.social · 15/12/2024
Check out our most recent work - A large database analysis of viral and fungal infections after CAR T cell therapy, published at @cmijournal.bsky.social, with @andhen25.bsky.social #IDSky #TxID www.clinicalmicrobiologyandinfection.com/article/S119...
clinicalmicrobiologyandinfection.com
DEFINE_ME
0152
Joseph Sassine @josephsassinemd.bsky.social · 15/12/2024
First post on #IDSky We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025. Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with! DM me for details! medicine.ouhsc.edu/academic-dep...
medicine.ouhsc.edu
Fellowship Opportunities
03315